Delivery Order SPE2DB22D1106-SPE2DB25FEBL3

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,468.55 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for Neulasta OnPro 6 mg/0.6 ml kits, a specialty pharmaceutical product. The contract has a firm fixed price and has an ultimate completion date of March 4, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,251.85, is for the delivery of Neulasta OnPro 6 mg/0.6 mL kits. This is a firm fixed-price delivery order with a completion date of June 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the supply of Neulasta OnPro pharmaceutical kits to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order valued at $9,183.96, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 firm fixed-price delivery order is for the supply of the drug Neulasta OnPro, a biologic medication used to help prevent infections in cancer patients undergoing chemotherapy. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2022. It...
This federal contract award, valued at $25,759.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support U.S. government medical requirements. The $21,560.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an existing Indefinite Delivery Contract (IDC) that has a total potential value of up to $999,999,999 for providing a comprehensive range of pharmaceutical and medical supplies to military treatment programs...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta, a specialty medication, with a ceiling value of $95,008.32. This is a firm fixed price delivery order contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of the pharmaceutical product Neulasta 6 mg/0.6 mL syringe to the Defense Logistics Agency (DLA). The contract, valued at $2,038.95, was awarded to the prime contractor Amerisourcebergen Drug Corp, which is the corporate office division of the larger Amerisourcebergen Corporation. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NEUPOGEN 480 MCG/1.6 ML vials. The $19,851.00 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEBL3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,306.08, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/3/25, 9:45 AM